Events/Photo Gallery https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology Sat, 30 May 2026 18:51:44 +0530 en-gb Dr. Sudhir Chandra Sarangi https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/5394-dr-sudhir-chandra-sarangi_pharmacology https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/5394-dr-sudhir-chandra-sarangi_pharmacology
{loadposition pharmacology}

 
 

Brief Biodata: Dr. Sudhir Chandra Sarangi

 

Name: Dr. Sudhir Chandra Sarangi, MBBS, MD, DM (Clinical Pharmacology), MAMS

                    डॉसुधीरचन्द्रसरंगी,
Designation: Additional Professor
               अपर प्रोफेसर

Affiliation: Department of Pharmacology, All India Institute of Medical Sciences, New Delhi

               भेषजगुण विज्ञान विभाग, अखिल भारतीयआयुर्विज्ञान संस्‍थान, नई दिल्‍ली

Address: Room No-5009, 5th Floor,

                 Department of Pharmacology,

                 Convergence Block,

                 All India Institute of Medical Sciences,

                 New Delhi-110029

Phone: +91 8518881757, 011-26549259

Email Id: scsarangi@gmail.com

Academic Details:

  • D.M. (Clinical Pharmacology) in the year 2013, All India Institute of Medical Sciences, New Delhi.
  • M.D. (Pharmacology)  in the year 2009, All India Institute of Medical Sciences, New Delhi
  • M.B.B.S (Hons)  in the year 2005, MKCG Medical College, Berhampur

Research Interest/Areas: Clinical Pharmacology, Neuropharmacology, Pharmacovigilance, Drug Safety, Pharmacoeconomics, Pharmacogenomics

Awards/Achievements:

  • Awarded membership by National Academy of Medical Sciences
  • Awarded ‘Bursary’  to attend the 34th International Epilepsy Congress by International League Against Epilepsy (2021)
  • Obtained Certificate of Achievement for poster presentation at 34th, 33rd and 32nd International Epilepsy Congress, 2021, 2019 & 2017.
  • Best Paper Award (2nd prize) in 20th Joint Annual Conference of Indian Epilepsy Society and Indian Epilepsy Association (ECON 2019)
  • Obtained ICMR International Travel support for Non-ICMR scientists for attending 33rd International Epilepsy Congress held at Bangkok, Thailand 22-26 June 2019.
  • Deputy coordinator of Adverse Drug Reaction Monitoring Center at AIIMS under Pharmacovigilance Programme of India

Publications (10 recent and relevant)

  1. Singh R, Sarangi SC, Singh S, Tripathi M. A review on role of metformin as a potential drug for epilepsy treatment and modulation of epileptogenesis. Seizure. 2022 Sep 5;101:253-261. 
  2. Mishra A, Reeta KH, Sarangi SC, Maiti R, Sood M. Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial. Psychopharmacology (Berl). 2022 Sep 7:1–11.
  3. Sarangi SC, Kumar S, Tripathi M, Kaleekal T, Singh S, Gupta YK. Antiepileptic-drug tapering and seizure recurrence: Correlation with serum drug levels and biomarkers in persons with epilepsy. Indian J Pharmacol. 2022 Jan-Feb;54(1):24-32.
  4. Mishra A, Sarangi SC, Maiti R, Sood M, Reeta KH. Efficacy and Safety of Adjunctive Serotonin-Dopamine Activity Modulators in Major Depression: A Meta-Analysis of Randomized Controlled Trials. J Clin Pharmacol. 2022 Jun;62(6):721-732.
  5. Sarangi SC, Medhi B, Prakash A, Prakash J, Gupta YK. Questionnaire-based Pan-India survey for impact assessment of National Formulary of India. Indian J Pharmacol. 2021 Mar-Apr;53(2):115-124.
  6. Sarangi SC, Sopory P, Reeta KH. Chronic Neurological Disorders: Genetic and Epigenetic Markers for Monitoring of Pharmacotherapy. Neurol India. 2021 Mar-Apr;69(2):252-259.
  7. Mishra A, Sarangi SC, Reeta K. First-in-human dose: current status review for better future perspectives. Eur J Clin Pharmacol. 2020 Sep;76(9):1237-1243.
  1. Sarangi SC, Kaur N, Tripathi M. Need for pharmacoeconomic consideration of antiepileptic drugs monotherapy treatment in persons with epilepsy. Saudi Pharm J. 2020;28(10):1228-1237.
  2. Sarangi SC, Pattnaik SS, Joshi D, Chandra PP, Kaleekal T. Adjuvant role of Ocimum sanctum hydroalcoholic extract with carbamazepine and phenytoin in experimental model of acute seizures. Saudi Pharm J. 2020 Nov;28(11):1440-1450.
  3. Kumar S, Sarangi SC, Tripathi M, Ramanujam B, Gupta YK. Seizure recurrence risk in persons with epilepsy undergoing antiepileptic drug tapering. Acta Neurol Scand. 2020 Jan;141(1):65-76.

 

Author of books/book chapters: Eight chapters

  1. Author of one chapter in ‘IAN Textbook of Neurology’ by Dr A. A. Mukherjee and Dr G. Singh. Edition 2018.
  2. Author of one chapter in ‘Nanogels in Biomedical Applications’ by A Vasisth, AK Kaushik, S Ahmad, M Nair, Royal Society of Chemistry, UK, Edition 2018.
  3. Author of six chapters in the book‐ 'Advanced Pharmacology' by B. Medhi& A. Prakash, Edition 2014.

             

             

]]> computerfacility.aiims@gmail.com (CF AIIMS) Pharmacology Thu, 14 Jul 2016 11:36:57 +0530 Pharmacology's Notice https://www.aiims.edu/index.php/en/2014-12-11-08-06-30/2014-12-11-08-06-58 https://www.aiims.edu/index.php/en/2014-12-11-08-06-30/2014-12-11-08-06-58
{loadposition pharmacology}
 
]]> computerfacility.aiims@gmail.com (CF AIIMS) Pharmacology Mon, 20 Jun 2016 12:16:09 +0530 Dr. Harlokesh Narayan Yadav https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/4246-dr-harlokesh-narayan-yadav_pharma_5_11 https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/4246-dr-harlokesh-narayan-yadav_pharma_5_11
{loadposition pharmacology}

 

Curriculum Vitae

 

Harlokesh Narayan Yadav

Associate Professor

Dept. of Pharmacology, AIIMS New Delhi

Phone Number-         Off- 011-26548565, Lab - 26549272

E-mail Id-                                    hnyadav@gmail.com

 

Research Interests:

 Teaching:

 

Involved in the Undergraduate and Post graduate teaching (MBBS and MD) and mentoring PhD students in All India Institute of Medical Sciences, New Delhi

Research:

 Major Area: Molecular Pharmacology/Cardiovascular Pharmacology/Nano-Pharmacology

 Cardiac ischemic-reperfusion injury, cardiac hypertrophy, cardiac failure and Pulmonary artery hypertension and In Vitro Screening

Awards and Professional activities:

 

  1. Gold medal for Dr. Manjeet Singh Award for best research work in the area of molecular Pharmacology by Indian Pharmacological Society.
  2. Gold medal for N.N. Datta Prize for best published work in Indian Journal of Pharmacology by Indian Pharmacological Society.

Memberships

  1. Serving as Secretary International of Indian Pharmacological Society, India
  2. National Academy of Medical Sciences, New Delhi
  3. Life Member of Indian Pharmacological Society (IPS)
  4. Life Member of Indian Society of Nanomedicine
  5. Life member of InPharm Association
  6. Life member of Indian Pharmacy Graduates Association (IPGA)

GUIDED: 40 PG Students

Experience: 13 Years of academic and research experience

 

Selected Research Publications:

http://livedna.org/91.817

                                                                      
]]> computerfacility.aiims@gmail.com (CF AIIMS) Pharmacology Fri, 06 Nov 2015 16:52:49 +0530 Dr Jagriti Bhatia https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2976-dr-jagriti-bhatia_pharma_11 https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2976-dr-jagriti-bhatia_pharma_11
{loadposition pharmacology}

 

Designation:                           Professor

Office Address:                     Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi  110 029 

Office Tel:                              011-2654 6476;  26593282

E-mail:                                    jagriti2012@rediffmail.com

Education:                             MBBS (Lady Hardinge Medical College, New Delhi, 1995) 

                                                MD Pharmacology (UCMS-GTB Hospital, Delhi, 1999)

Departmental duties:            Engaged in teaching of  MBBS (3rd, 4th and 5th Semester), BSc Nursing (Hons), MSc, MD and PhD students

Field of Research:                 Herbal (Indigenous) Pharmacology

                                                Cardiovascular Pharmacology

                                                Nephrotoxicity

                                                Pulmonary fibrosis

 

Awards

 

  1. AIIMS Excellence Research Award 2015 Commendation Certificate for the year 2014-2015.
  2. ISH 2014 International Forum Poster Prize for the Asia and Australasia Region at Athens, Greece, 2014.

Research Publications

  1. Gamad N,  Malik S, Suchal K, Vasisht S, Tomar A, Arava S, Arya DS, Bhatia J. Metformin alleviates bleomycin-induced pulmonary fibrosis in rats: Pharmacological effects and molecular mechanisms. Biomed Pharmacother  2018; 97: 1544–1553.
  2. Khan SI, Malhotra RK, Rani N, Sahu AK, Tomar A, Garg S, Nag TC, Ray R, Ojha S, Arya DS, Bhatia J. Febuxostat Modulates MAPK/NF-κBp65/TNF-α Signaling in Cardiac Ischemia-Reperfusion Injury.Oxid Med Cell Longev. 2017;2017:8095825. 
  3. Tomar A, Vasisth S, Khan SI, Malik S, Nag TC, Arya DS, Bhatia J. Galangin ameliorates cisplatin induced nephrotoxicity in vivo by modulation of oxidative stress, apoptosis and inflammation through interplay of MAPK signaling cascade. Phytomedicine.2017;34:154-161.
  4. Malik S, Suchal K, Khan SI, Bhatia J, Kishore K, Dinda AK, Arya DS. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK/NF-κB/TNFα and TGF-β1/MAPK/Fibronectin pathways.Am J Physiol Renal Physiol.2017;313(2):F414-F422.
  5. Suchal K, Malik S, Gamad N, Malhotra RK, Goyal SN, Bhatia J, Arya DS. Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats.Phytomedicine. 2016;23(12):1401-1408.
  6. Malik S, Suchal K, Bhatia J, Khan SI, Vasisth S, Tomar A, Goyal S, Kumar R, Arya DS, OjhaSK.Therapeutic Potential and Molecular Mechanisms of Emblica officinalisGaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin. Front Pharmacol 2016;7:350. eCollection 2016.
  7. Rani N, Bharti S, Tomar A, Dinda AK, Arya DS, Bhatia J. Inhibition of PARP activation by enalapril is crucial for its renoprotective effect in cisplatin-induced nephrotoxicity in rats.Free Radic Res 2016;50(11):1226-1236.    
  8. Malik S, Suchal K, Bhatia J, Gamad N, Dinda AK, Gupta YK, Arya DS. Molecular mechanisms underlying attenuation of cisplatin-induced acute kidney injury by epicatechingallate. Lab Invest.2016; 96(8):853-61.
    1. Malik S, Suchal K, Gamad N, Dinda AK, Arya DS, Bhatia J .Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis.Eur J Pharmacol. 2015; 748:54-60.  
  1. Malik S, Bhatia J, Suchal K, Gamad N, Dinda AK, Gupta YK, Arya DS. Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects.ExpToxicolPathol. 2015;67(7-8):427-33. 

 

]]> computerfacility.aiims@gmail.com (CF AIIMS) Pharmacology Mon, 11 May 2015 16:33:36 +0530 DR. SURENDER SINGH https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2965-dr-surender-singh_phar_9_5 https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2965-dr-surender-singh_phar_9_5
{loadposition pharmacology}

 

DR. SURENDER SINGH

 

DOB: 27th May1963

PROFESSOR

Department of Pharmacology,

All India Institute of Medical Sciences,

Ansari Nagar New Delhi - 110 029, INDIA

Tel: +91-11-2654-6460,  09810882350

E-mail:  surenderaiims@gmail.com

 

RESEARCH AND PUBLICATIONS

ACADEMIC ACHIEVEMENTS

1. Published >100 Research Papers (Total Impact Factor 125.02, Citation-3200, h-Index- 29)

2. Authored 06 Books/Scientific Series & chapters in book.

3. Guided 48 Theses (PhD-18, MD/MDS -19, M.Pharm / MSc-08).

4. Completed 20 Research projects funded by ICMR, DBT, AIIMS, AYUSH, Govt. of India.

Awards:

1.Gold Medal, M.Pharm. (Pharmacology) DIPSAR (University of Delhi), 1989.

2.JSPS-Asia Africa Science Platform Programme, Japan Best Paper Award, 2011.

3. Indian Council of Medical Research (ICMR) Award for Biomedical Research, 2013.

4. All India Institute of Medical Sciences (AIIMS) Excellence Research Award, 2016.

5. Dr. B. Mukherjee Prize for Best paper in Indian Journal of Pharmacology, 2016.

6. Dr. D.N. Prasad Memorial Oration Award, ICMR for Biomedical Research, 2017.

 

Fellowships/ Honours:

1. Fellow of National Academy of Medical Sciences (FAMS), India.     

2. Fellow of Royal Society of Chemistry (FRSC), United Kingdom.

3. Fellow of International Medical Science Academy (FIMSA), India.

4. Fellow of Institution of Chemists (FIC), India.

5. D.Sc. (Honoris Causa), Colombo, Sri Lanka.

6. Fellow of International Council of Ayurveda (FICA), India.

 

RESEARCH AREA

Inflammation, Rheumatoid Arthritis, Indigenous drugs, Medicinal Plant Research

RESEARCH PAPERS

1.   Surender Singh and DK Majumdar (1999).

      Evaluation of gastric antiulcer activity of fixed oil of Ocimum sanctum (Holy Basil)

      Journal of Ethnopharmacology, 65:13-19. (IF:3.055)             

2.   MA Jafri, M Jalis Subhani, Kalim Javed and Surender Singh (2000)

      Hepatoprotective activity of leaves of Cassia Occidentalis against paracetamol and ethyl alcohol intoxication in rats.

      Journal of Ethnopharmocology - 66:355-361. (IF:3.055)             

3.   MA Jafri, M Aslam, Kalim Javed and Surender Singh (2000)

      Effect of Punica granatum Linn (flowers) on blood glucose levels in normal and alloxan induced diabetic rats.

      Journal of Ethnopharmacology - 70:309-314. (IF:3.055)               

4.   MA jafri, Farah, Kalim Javed K and Surender Singh (2001)

      Evaluation of the gastric antiulcerogenic effect of large cardamom (fruits of Ammomum subulatum Roxb.)

      Journal of Ethnopharmacology 75:89-94. (IF:3.055)  

          

5.   Surender Singh, HMS Rehan and DK Majumdar (2001)

      Effect of Ocimum sanctum fixed oil on blood pressure, blood clotting time and pentobarbitone - induced sleeping time.

      Journal of Ethnopharmacology ,78:139-143. (IF:3.055)             

6.   PK Mediratta, KK Sharma and Surender Singh (2002)

      Evaluation of Immunomodulatory potential of Ocimum sanctum seed oil and its possible mechanism of action.

      Journal of Ethnopharmacology, 80:15-20. (IF:3.055)             

          

7. Vinod Nair , Surender Singh and YK Gupta (2011).

Evaluation of the disease modifying activity of Colchicum luteum Baker in. experimental arthritis.

      Journal of Ethnopharmacology, 133: 303-307. (IF:3.055)             

 

8.Surender  Singh, Vinod Nairand Yogendra K Gupta (2012).

     Evaluation of the aphrodisiac activity of Tribulus terrestris Linn. in sexually sluggish male albino rats.

      Journal of Pharmacology & Phamacotherapeutics , 3(1): 43-47.

 

9. Ritu Karwasra, Prerna Kalra, YK Gupta, Deepika Saini, Ajay Kumar and Surender        Singh (2016).

Pomegranate antioxidant and anti-inflammatory potential ameliorates renoprotection  in cisplatin-induced acute kidney injury.

Food and Function, 7: 3091-3101 (IF: 2.791).

10. Rohit Kumar, Vinod Nair, YK Gupta, Surender Singh and S.Arunraja (2016).

Berberis aristata ameliorates adjuvant-induced arthritis by inhibition of NF-κB and       activating nuclear factor-E2-related factor 2/hem oxygenase (HO)-1 signaling pathway.

Immunological investigations, 45(6): 473-489. (IF: 1.780).

 
]]> computerfacility.aiims@gmail.com (CF AIIMS) Pharmacology Sat, 09 May 2015 13:23:25 +0530 Dr Pooja Gupta https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2964-dr-pooja-gupta-phar-9-5-15 https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2964-dr-pooja-gupta-phar-9-5-15
{loadposition pharmacology}

 
 

Dr Pooja Gupta MD, DM, MAMS

 Professor

drgupta.pooja@aiims.gov.in; drgupta.pooja@aiims.edu

Off: +91-11-26549257 (Ext.)/ *8557 (Int.)

 

डॉ पूजा गुप्ता

आचार्य

भेषजगुण विज्ञान विभाग,

अखिल भारतीयआयुर्विज्ञान संस्‍थान, नई दिल्‍ली

 

Academic details:

  • DM (Clinical Pharmacology), All India Institute of Medical Sciences, New Delhi.

  • MD (Pharmacology), Maulana Azad Medical College, New Delhi  

  • MBBS, Lady Hardinge Medical College, New Delhi

 

Address: Room No 5004, 5th Floor, Department of Pharmacology, Convergence Block, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029

Areas of Interests: Clinical Pharmacology, oncopharmacology, pharmacovigilance, regulatory pharmacology, pharmacoeconomics, bioethics  

Awards/ Achievements/ Contributions:

  • Professor-in-charge, Computer Facility

  • AIIMS center coordinator for adverse event monitoring of drugs and medical devices under Pharmacovigilance Program of India and Materiovigilance Program of India

  • Member secretary, Institute Ethics Sub-Committee for SAEs in Clinical Trials, AIIMS

  • Member and Workshop Coordinator, Working Committee, Clinical research unit, AIIMS, New Delhi

  • Member, National Adverse Events Following Immunization (AEFI) Subcommittees (causality assessment and advocacy & media), MoH&FW, GoI

  • Member, Subcommittee for medicines under Standing National Committee on Medicines and other Health Care Products, MoH&FW, GoI

  • Involved in >15 research projects funded by ICMR, DST, AIIMS, AYUSH, Govt. of India; Guided >20 theses as Guide/Co-guide (PhD/DM/MD/MS/MDS/MSc); and have >40 publications with an h-index of 13.

 

Publications (selected 10):

  1. Malhotra S, Kalaivani M, Lodha R, Bakhshi S, Mathur V, Gupta P, Kedia S, Sankar J, Kumar P, Kumar A, Ahuja V, Sinha S, Guleria R, COVID Reinfection AIIMS Consortium. COVID-19 infection, and reinfection, and vaccine effectiveness against symptomatic infection among health care workers in the setting of omicron variant transmission in New Delhi, India. Lancet Reg Health Southeast Asia. 2022. DOI: 10.1016/j.lansea.2022.100023. 

  2. Malhotra S, Kalaivani M, Lodha R, Bakhshi S, Mathur V, Gupta P, Kedia S, Sankar J, Kumar P, Kumar A, Ahuja V, Sinha S, Guleria R, COVID Reinfection AIIMS Consortium. SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India. JAMA Network Open. 2022;5(1):e2142210. DOI: 10.1001/jamanetworkopen.2021.42210

  3. Kajal S, Naeem SS, Gupta P*, Kairo AK, Ahmed A, Verma P, Saini A. Sinonasal mucormycosis and liposomal amphotericin B: A quest for dose optimization. Ind J Pharmacol. 2022;54(2):90-96.

  4. Gupta P, Naeem SS, Mohan P, Banerjee A. Is written informed consent cast in iron even during a Pandemic? [Editorial]. Med J Armed Forces India. 2020;76:367-9.

  5. Diksha, Gupta P*, Malik PS, Mohan A. A pilot study of oxidative and inflammatory markers as early indicator for response to platinum-based chemotherapy in non-small cell lung cancer patients. J Clin Pharm Ther. 2019; 00: 1– 6. https://doi.org/10.1111/jcpt.13053

  6. Gupta P, Anvikar A, Valecha N, Gupta YK. Pharmacovigilance Practices for Better Healthcare Delivery: Knowledge and Attitude Study in the National Malaria Control Programme of India. Malar Res Treat 2014; 2014: 837427. doi:10.1155/2014/837427

  7. Gupta P, Mehla J, Gupta YK. Antiobesity effect of Safoof Mohazzil, a Unani herbal formulation, in cafeteria diet induced obesity in rats. Indian J Exp Biol 2012; 50: 776-84.

  8. Gupta P, Gupta V, Gupta YK. Anticancer Phase I Clinical Trials in Healthy Volunteers: need for critical consideration. Indian J Pharmacol. 2012; 44: 540-42. 

  9. Padhy BM, Gupta P, Gupta YK. Analysis of the compliance of informed consent documents with good clinical practice guideline. Contemp Clin Trials. 2011; 32: 662-666.

  10. Gupta P, Roy V, Sethi GR, Mishra TK. Pyrazinamide blood concentrations in children suffering from tuberculosis: a comparative study at two doses. Br J Clin Pharmacol. 2008; 65(3): 423-427.

*Corresponding Author

]]> computerfacility.aiims@gmail.com (CF AIIMS) Pharmacology Sat, 09 May 2015 12:57:27 +0530 Dr. Vijay L. Kumar https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2560-dr-vijay-l-kumar-20-2-15 https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2560-dr-vijay-l-kumar-20-2-15
{loadposition pharmacology}

Dr. Vijay L. Kumar

(डॉ.विजय एल. कुमार)

 

Present Position: Professor and Head आचार्य एवं अध्यक्ष, Department of Pharmacology भेषजगुण विज्ञान विभाग, AIIMS, New Delhi  अ.भ.आ.सं.,  नईदिल्ली

Email: kumarvl98@gmail.com   

Education: M.Sc. (Pharmacology): All India Institute of Medical Sciences, New Delhi

Ph.D.: All India Institute of Medical Sciences, New Delhi

Postdoctoral Research: Institut de Chimie Biologique, Strasbourg, France

 

Awards and Honors:  

British Government fellowship for training in Medical Education and Technology, 1990.  

Chandra Kanta Dandiya Prize of Prem Chand Dandiya Endowment Trust for best research publication in Pharmacology, 1999.  

C.L. Malhotra Research Prize in Pharmacology by the Association of Physiologists and Pharmacologists of India for research, 2000. 

A.V. Tilak Parvathy Devi Prize by the Association of Physiologists and Pharmacologists of India for best research paper in endocrinology, 2006. 

Dev Raj Bajaj Research Prize by the Association of Physiologists and Pharmacologists of India for the best research paper in developing a new technique, 2009.

AIIMS Excellence Research Award 2020 under the category Basic Sciences

 

Member - National Academy of Medical Sciences, India, 2004.

 

Member – National Academy of Sciences, India, 2007.

 

Research Interest:

  • Anti-cancer and anti-inflammatory mechanisms of drugs and botanicals.

  • Molecular biology of steroid receptors, regulation of receptors and its relevance in hormone dependent cancers.

  • Awareness for poison prevention

Outline of Research:

  • Anti-inflammatory, analgesic and antiarthritic properties of non-protein and protein fractions of latex of Calotropis procera and the effect of these fractions on inflammatory and oxidative stress markers.

  • Other medicinal properties of latex of C. procera - Antipyretic, antidiarrhoeal, antihyperglycemic, anticancer, hepatoprotective, antiulcer, maintenance of coagulation homeostasis in in vivo models.

  • Purification and pharmacological characterization of active constituents of latex of C. procera.

  • Pleiotropic effects of drugs and plant derived preparations - atorvastatin, artesunate.

  • Development of models for screening of anti-inflammatory and cytotoxic drugs.

  • Trends on poisoning based on analysis of data of National Poisons Information Centre related to accidental and intentional exposure to various products.

  • Differentially expressed genes associated with lead exposure and their functional relevance, protein-protein interaction and identification of hub genes.

  • Steroid and growth factor receptors - in vivo regulation and implication to prostate cancer, regulatory mechanisms and splice variants of estrogen receptor in breast cancer.

Selected Publications:

  1. Kumar V.L., Majumder P.K. and Kumar V. Androgen deprivation causes up-regulation of androgen receptor transcript in the rat prostate. Mol. Cell. Biochem. 171: 133-138, 1997.

  2. Kumar V.L.,Majumder P.K., Gujral S., Kumar V. Comparative analysis of epidermal growth factor receptor mRNA levels in normal, benign hyperplastic and carcinomatous prostate. Cancer Letters 134: 177-180, 1998.

  3. Kumar V.L., Kumar S., Srivastava A. and Kumar V. Observations on the presence of E domain variants of estrogen receptor-α in the breast tumors. J Surg. Oncol. 94: 332-337, 2006.

  4. Wahane V.D. and Kumar V.L. Atorvastatin ameliorates inflammatory hyperalgesia in rat model of monoarticular arthritis. Pharmacol. Res.61: 329-333, 2010.

  5. Guruprasad B., Chaudhary P., Choedon T. and Kumar V.L. Artesunate ameliorates functional limitations in Freund’s complete adjuvant-induced monoarthritis in rat by maintaining oxidative homeostasis and inhibiting COX-2 expression. Inflammation 38: 1028-1035, 2015.

  6. Verma S., Das P. and Kumar V.L. Chemoprevention by artesunate in a preclinical model of colorectal cancer involves down regulation of β-catenin, suppression of angiogenesis, cellular proliferation and induction of apoptosis. Chem. Biol. Interact. 278: 84-91, 2017.

  7. Kumar V.L., Pandey A., Verma S. and Das P. Protection afforded by methanol extract of Calotropis procera latex in experimental model of colitis is mediated through inhibition of oxidative stress and pro-inflammatory signaling. Biomed. Pharmacother. 109: 1602-1609, 2019.

  8. Vangaveti S., Das P. and Kumar V.L. Metformin and silymarin afford protection in cyclosporine A induced hepatorenal toxicity in rat by modulating redox status and inflammation. J. Biochem. Mol. Toxicol. 2020 doi: 10.1002/jbt.22614.

  9. Kumar V.L., Verma S. and Das P. Protective effect of methanol extract of latex of Calotropis procera in an experimental model of colorectal cancer. J. Ethnopharmacol. 2022 doi: 10.1016/j.jep.2021.114668.

  10. Sharma S., Kumar V.L., Bhardwaj A.Identification of critical genes associated with lead exposure based on in silico analysis. Toxicol. Ind. Health 39: 356-363, 2023.

 

]]> computerfacility.aiims@gmail.com (CF AIIMS) Pharmacology Fri, 20 Feb 2015 14:25:01 +0530 DR. KH REETA https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2559-dr-kh-reeta-20-2-15 https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2559-dr-kh-reeta-20-2-15
{loadposition pharmacology}

                                                            

KH REETA, MBBS, MD

केएच रीता

PRESENT POSITION:  Professor/आचार्य

 

CONTACT DETAILS

Room: 4029, कमरा: ४०२९

Department of Pharmacology, भेषजगुण विज्ञान विभाग

All India Institute of Medical Sciences, New Delhi-110029

अखिल भारतीय आयुर्विज्ञान संस्‍थान, नई दिल्‍ली- ११००२९

Telephone: 011-26593247

Mobile No. 9711204141

Email:reetakh@gmail.com; drkhreeta@aiims.edu

 

RESEARCH INTERESTS/ ACTIVE RESEARCH AREAS

  • Neuropharmacology, Metabolic Disease, Clinical Pharmacology

 

AWARDS  

  • AIIMS Excellence Research Award 2022 for outstanding publication under the category Basic Research, awarded in 2024.

  • Fellow, Indian Pharmacological Society (FIPS) 2023.

  • Fellow, National Academy of Medical Sciences, India (FAMS)(F-1080-2022).

  • Dr Vinod Kumar Bhargava Award of the National Academy of Medical Sciences for best published research work in the field of Clinical Pharmacology/Drug Development in India, 2017.

  • AIIMS Excellence Research Award for outstanding publication under the category Basic Research, 2016.

  • Shakuntala Amir Chand Award of ICMRfor the best published research work in the field of biomedical science including clinical research, awarded in the year 2013.

  • Member, National Academy of Medical Sciences, India (2011).

  • CL Malhotra Prize, for the best research paper in Pharmacology, presented by the Association of Physiologists & Pharmacologists of India (2006).

  • Best Oral Paper Presented, 3rd North Zone Conference of Indian Pharmacological Society, New Delhi, presented by the Indian Pharmacological Society (2005).

  • Ranked First, Research Methodology and Biostatistics (1997)

  • Stood First, all Professional MBBS Examinations

  • Honors and Topped in Internal Medicine, Surgery, Obstetrics & Gynecology, Community Medicine, Otolaryngology, Pharmacology, Anatomy and Biochemistry.

  • Topped in Ophthalmology, Pathology, Forensic Medicine and Physiology.

  • Kamala Devi Patni Charitable Gold Medal for the Best Graduate of the Institute (1994): recognition for excellence in Clinical Skills and Overall Achievements.

  • University Gold Medalsin Internal Medicine, Surgery, Pharmacology and for standing First in Final MBBS.

  • Certificate and Cash Awardfor scoring above 70% in Internal Medicine.

  • Dashmesh Endowment Prize from the Association of Otolaryngologists of Indiafor Honors in Otolaryngology.

 

KEY PUBLICATIONS (10)  

  1. Sharma H, Reeta KH, Sharma U, Suri V, Singh S. AMPA receptor modulation through sequential treatment with perampanel and aniracetam mitigates post-stroke damage in experimental model of ischemic stroke.Naunyn Schmiedebergs Arch Pharmacol 2023; 396(12):3529-3545.

  1. Mishra A, Sarangi SC, Maiti R, Sood M, Reeta KH. Effect of add-on alpha lipoic acid on psychopathology in patients with treatment resistant schizophrenia: A pilot randomized double-blind placebo-controlled trial. Psychopharmacology (Berl). 2022:1-11. doi: 10.1007/s00213-022-06225-2.

  1. Joshi B, Singh D, Wasan H, Sharma U, Reeta KH. Tideglusib ameliorates ischemia/reperfusion damage by inhibiting GSK-3β and apoptosis in rat model of ischemic stroke.J Stroke Cerebrovasc Dis. 2022;31(4):106349.

  1. Mishra A, Sarangi SC, Maiti R, Sood M, Reeta KH. Efficacy and safety of adjunctive serotonin-dopamine activity modulators in major depression: a meta-analysis of randomized controlled trials. J Clin Pharmacol. 2022;62(6):721-732.

  1. Wasan H, Singh D, Joshi B, Sharma U, Dinda AK, Reeta KH.Post stroke safinamide treatment attenuates neurological damage by modulating autophagy and apoptosis in experimental model of stroke in rats. Mol Neurobiol. 2021.58(12):6121-6135. doi: 10.1007/s12035-021-02523-6.

  1. Verma V, Singh D,  Reeta KH.Sinapic acid alleviates oxidative stress and neuro-inflammatory changes in sporadic model of Alzheimer's disease in rats.Brain Sci. 2020;10(12):E923.

  1. Meenu M, Reeta KH, Dinda A K, Kottarath SK, Gupta YK. Evaluation of sodium valproate loaded nanoparticles in acute and chronic pentylenetetrazole induced seizure models. Epilepsy Res 2019; 158: 106219.

  1. Singh D, Reeta KH, Sharma U, Jagannathan NR, Dinda AK, Gupta YK. Neuro-protective effect of monomethyl fumarate on ischemia reperfusion injury in rats: Role of Nrf2/HO1 pathway in peri-infarct region.Neurochem Int. 2019;126:96-108.

  1. Reeta KH, Singh D, Gupta YK. Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation. Neurochem Int 2017; 108: 146-156.

  1. Prabhakar P, Reeta KH, Maulik SK, Dinda AK, Gupta YK. Protective effect of thymoquinone against high fructose diet-induced metabolic syndrome in rats. Eur J Nutr 2015; 54:1117-1127.

 

For other publications please click on to:

https://pubmed.ncbi.nlm.nih.gov/?term=reeta+kh&sort=date

 

]]> computerfacility.aiims@gmail.com (CF AIIMS) Pharmacology Fri, 20 Feb 2015 14:15:57 +0530 Dr. D S Arya https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2558-dr-d-s-arya-phar-20-2-15 https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2558-dr-d-s-arya-phar-20-2-15
{loadposition pharmacology}

 

1. Name: Dr. D. S. Arya

2. Current Designation:  Professor

Department of Pharmacology

All India   Institute of Medical Sciences

New Delhi-110029

 

3. Contact Details: Room No. 4028, Cardiovascular Pharmacology Laboratory,

Department of Pharmacology, All India   Institute of Medical Sciences, New Delhi-110029

Telephone: 011-26594266

                                Email ID: dsarya16@gmail.com; dsarya16@aiims.edu

 

5. Education:    MBBS:  All India Institute of Medical Sciences, New Delhi

                           MD: All India Institute of Medical Sciences, New Delhi

                           PhD: All India Institute of Medical Sciences, New Delhi           

  

4. Research Interest/ area: 

Cardiovascular Pharmacology,

Diabetes

Prostate Cancer

Cardiac Immunology

 

5.  Awards/ Achievements:

·        ICMR Chaturvedi Kalawati Jagmohan Das Memorial Award for outstanding research in cardiovascular disease 2016.

·       AIIMS Excellence Research Award 2016 under the category of Basic Research.

·       ­­­­AIIMS Excellence Research Award 2015 under the category of Basic Research.

·       AIIMS Excellence Research Award 2014 under the category of Basic Research..

·       Smt. Saroj Sharma Prize from Indian Pharmacological Society, for best Research Publication in Cardiovascular Pharmacology.

·       G. Achari Prize from Indian Pharmacological Society for best Research work in Pharmacology.

·       Young Investigator Award by International Society for Heart Research and Indian Academy of Cardiovascular Sciences, 2004.

 

6. Teaching and Research Activities:

   Teaching 

  • MBBS, MD, DM, M.Sc. and nursing Teaching for 25 years in pharmacology.

Research 

  • Research Experience for over 25 years on Cardiovascular diseases, Cardiac immunology, Diabetes and its complications, Cancer, Tuberculosis, Nephropathy, and Pulmonary fibrosis and published many Research articles in related fields.

7. Vision:

  • To use virtuosity for the scientific growth of our nation and to engage in governmental, community, and pharmacological endeavours.

  • To encourage scholastic success through effective instruction and information sharing.

  • To guarantee that the department's actions have a significant impact on the pharmaceutical sector, national drug laws and regulations, and patient’s quality of life.

 

Key Publication:

·       For research articles of Dr. D. S. Arya Please click on to hyperlink:

https://pubmed.ncbi.nlm.nih.gov/?term=arya+ds&sort=date&size=50

 

]]> computerfacility.aiims@gmail.com (CF AIIMS) Pharmacology Fri, 20 Feb 2015 14:03:26 +0530 Mini International Symposium on Drug Discovery and Development https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2407-mini-international-symposium-on-drug-discovery-and-development https://www.aiims.edu/index.php/en/2015-01-08-12-03-07/112-pharmacology/2407-mini-international-symposium-on-drug-discovery-and-development

 

Mini International Symposium

on

Drug Discovery and Development: Case Studies

 Organized by

Department of Pharmacology

All India Institute of Medical Sciences

On 30th October, 2007 (Tuesday)

08:30 AM to 01:30 PM

Venue: Board Room, AIIMS

0 8:30AM – 09:00AM

Registration

0 9:00AM – 09:15AM

Inauguration, Guest of Honor:  Prof. R C Deka, Dean, AIIMS

                                                        Mr. A B Ramteke, Joint Drugs Controller (India)

                                                       Sh. N C Dhawan, DDG, MOH&FW, India

0 9:15AM – 09:30AM

Introduction to Symposium

Dr. Y K Gupta

Professor & Head, Deptt. of Pharmacology, AIIMS

0 9:30AM - 10:10AM

Key Note Address: Identification & characterization of novel therapeutics for treatment of refractory epilepsy

Prof. H Steve White

Director, Anticonvulsant Drug Development Programme, University of Utah, USA

1 0:10AM – 10:30AM

Hit to Lead: Discovery of a potent and orally active IP receptor antagonist

Dr. J B Gupta

Senior Vice President, GVK Biosciences, Hyderabad

1 0:30AM – 10:50AM

India: A hub of early clinical development

Dr. Kamala Rai

Research Director, MSD Pharmaceuticals, India

1 0:50AM – 11:10AM

Tea

1 1:10AM – 11:30AM

How do I get my findings published

Dr. Amitabh Prakash

Editor, American Journal of  

Cardiovascular drugs,

Cardiovascular Medicine, New Zealand

1  1:30AM – 11:50AM

Role of an endothelin agonist in the treatment of cancer

Prof. Anil Gulati

Associate Dean, Chicago College of Pharmacy, USA

1 1:50AM – 12:10PM

A case study of changing Technology: Convention to Phaco in Cataract 

Mr.  Jawed Zia

Managing Director, Alcon Laboratories Pvt. India

1 2:10PM – 12:45PM

Panel Discussion and summing up

Moderator:  Y K Gupta

Panelist:  H Steve White, J B Gupta,   

Kamala Rai, Amitabh

Prakash,  Anil Gulati

Jawed Zia, Joseph Dunn  

(CEO,  EndogenX, USA)

1 2:45PM – 01:00PM

AIIMS-PHARMA-ALUMNI Awards Ceremony

Awardees :-

Dr. J B Gupta,  Dr. Amitabh Prakash

Dr. Kamala Rai,  Mr.  Jawed Zia

0 1:00PM – 01:15PM

Vote of thanks

Dr. D S Arya,

Associate Professor, Deptt. of Pharmacology, AIIMS

0 1:15PM

Lunch 
]]> pankaj@pwt.in (pankaj) Pharmacology Fri, 30 Jan 2015 12:04:48 +0530